EPITOPE SUMMARY | |
---|---|
SLYNTVATL is a linear peptidic epitope (epitope ID ) studied as part of Gag polyprotein (UniProt:P04591) from Human immunodeficiency virus 1 (human immunodeficiency virus 1 HIV-1) and Gag-Pol polyprotein (UniProt:P04585) from Human immunodeficiency virus 1 (human immunodeficiency virus 1 HIV-1). This epitope has been studied for immune reactivity in publication(s), tested in T cell assays, MHC ligand assays and has 3D structure(s) , , and . |
CURATED EXPERIMENTAL DATA | |
---|---|
MHC Ligand Assay(s) | |
MHC molecule | Positive / All |
HLA-A*02:01 | / |
HLA-A*02:02 | / |
HLA-A*02:03 | / |
HLA-A*02:06 | / |
HLA-A*02:11 | / |
HLA-A*02:19 | / |
HLA-A2 | / |
HLA-B*15:01 | / |
HLA-A*02:05 | / |
HLA-A*02:14 | / |
HLA-A*68:02 | / |
HLA-A*69:01 | / |
HLA-B*07:02 | / |
T Cell Assay(s) | |
Assay Type | Positive / All |
qualitative binding | / |
IFNg release | / |
activation | / |
dissociation constant KD | / |
cytotoxicity | / |
CCL4/MIP-1b release | / |
off rate | / |
on rate | / |
3D structure | / |
TNFa release | / |
IL-2 release | / |
EXTERNAL RESOURCES | |
---|---|
Resource | Link |